NCT06761001 is a NA clinical trial of I-PRF in Alveolar Osteitis, sponsored by Eskisehir Osmangazi University.

Who is sponsoring NCT06761001?

NCT06761001 is sponsored by Eskisehir Osmangazi University.

What drugs are being tested in NCT06761001?

Interventions in NCT06761001: I-PRF, Control.

What condition does NCT06761001 study?

NCT06761001 studies Alveolar Osteitis, Pain, Dry Socket.

Is NCT06761001 still recruiting?

NCT06761001 is currently completed. Last updated 19 February 2025.

Last reviewed 2025-02-19 · How we verify

NCT06761001

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigation of the Effect of I-PRF Application on Pain in Alveolitis

Completed NA Last updated 19 February 2025

What this trial tests

NA trial testing I-PRF in Alveolar Osteitis in 60 participants. Completed in 18 February 2025.

Timeline

20 October 2024

Primary endpoint
18 February 2025

18 February 2025

Quick facts

Lead sponsor	Eskisehir Osmangazi University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	60
Start date	20 October 2024
Primary completion	18 February 2025
Estimated completion	18 February 2025
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

I-PRF
Control

Conditions studied

Alveolar Osteitis — all drugs for Alveolar Osteitis →
Pain — all drugs for Pain →
Dry Socket — all drugs for Dry Socket →

Sponsor

Eskisehir Osmangazi University

Who can join

18 and older, any sex, with Alveolar Osteitis or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Literature review showed that there are no studies on the use of i-PRF in alveolitis cases. The aim of this study was to investigate the effect of i-PRF on the treatment of alveolitis. The hypothesis of the study was that i-PRF applied to alveolitis patients would reduce pain.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Is injectable platelet-rich fibrin really effective in alveolar osteitis? a randomised controlled clinical trial.
Tekin G, Türedi SÖ. · · 2025 · PMID 40420265 · DOI 10.1186/s12903-025-06257-y

Verify or expand the search:

Other trials of I-PRF

Trials testing the same drug.

NCT06936358 — Injectable Platelet-rich Fibrin and Advanced Platelet-rich Fibrin With Xenograft on the Socket Preservation of Mandibula · NA · completed
NCT07373730 — Evaluation of the Efficacy of Injectable Platelet-Rich Fibrin Mixed With Hyaluronic Acid in Treatment of Temporomandibul · NA · completed
NCT05389059 — Injectable Platelet Rich Fibrin With Collagen Matrix in Treatment of Multiple Gingival Recession. · NA · unknown
NCT04029779 — Evaluation of Immediately Placed Dental Implants With Local Application of Injectable PRF in Periodontally Compromised S · Phase 2 · completed
NCT03274674 — Use of Injectable-platelet-rich-fibrin (I-PRF) to Thicken Gingival Phenotype · NA · completed

Other recruiting trials for Alveolar Osteitis

Currently open trials in the same condition.

NCT06435832 — Evaluations of the Effects of Tranexamic Acid and Chlorhexidine Gel on Alveolar Osteitis Incidence · NA · active not recruiting

Other Eskisehir Osmangazi University trials

Trials by the same sponsor.

NCT07343505 — Environmental Enrichment Intervention and Brain Development in Preterm Infants · NA · not yet recruiting
NCT07346963 — RSV-Positive Children <5 Years Presenting to Pediatric Emergency Departments in Türkiye: TRUST-RSV · not yet recruiting
NCT07342101 — Evaluating the LGG of on Acute Infectious Diarrhea in Children · NA · not yet recruiting
NCT07307924 — The Effect of Motivational Interviewing on Knowledge, Self-Efficacy, and Treatment Adherence in Patients With Primary Hy · NA · enrolling by invitation
NCT07131267 — Evaluating Sexual Functioning in Trans Men During the Gender Affirmation Process: A Mixed Methods Study · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06761001 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Eskisehir Osmangazi University
Last refreshed: 19 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06761001.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing